Anti-Aging Potential of Acetyl Aspartic Acid Characterized

This article originally appeared here.
Share this content:
Anti-Aging Potential of Acetyl Aspartic Acid Characterized
Anti-Aging Potential of Acetyl Aspartic Acid Characterized

WEDNESDAY, July 15, 2015 (HealthDay News) -- New research published online July 3 in the International Journal of Cosmetic Science has characterized the anti-aging potential of acetyl aspartic acid (A-A-A).

Johanna Gillbro, Ph.D., from Oriflame Skin Research in Stockholm, and colleagues used structural activity relationship (SAR) analysis to identify a predictive mechanism of action of A-A-A. Wound healing potential was assessed in vitro using scratch motility tests with immortalized keratinocytes. Multiplex protein assays were used to analyze matrix metalloproteinase 1-3 (MMP 1-3), and polymerized actin was stained in human dermal fibroblasts (HDF).

Based on SAR analysis, the researchers predicted that A-A-A would possess epidermal and dermal activities, with wound healing and MMP-inhibition potential detected. Wound healing potential was confirmed using keratinocyte scratch motility assays. The dermal activities predicted by A-A-A inhibition of MMP 1-3 in HDF were confirmed. There was a positive association between age and F-actin. Seventy-two hour stimulation of HDF with A-A-A reduced the polymerized cytoskeletal network, as seen by F-actin expression inhibition. In middle-aged female fibroblasts (50 years), A-A-A leveraged F-actin expression to the level of young female fibroblasts (30 years), corresponding to a 40 percent decrease in F-actin expression.

"Using an in silico and in vitro approach, we were able to demonstrate that A-A-A has the capacity to target different compartments of the skin through keratinocyte regeneration, MMP-inhibition, and relief in fibroblasts stiffness by reduction of F-actin cytoskeletal network in HDF," the authors write.

The study was funded by Oriflame Cosmetics AB.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths